Navigation Links
BioMarin to Present at the J.P. Morgan Healthcare Conference
Date:1/3/2012

NOVATO, Calif., Jan. 3, 2012 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9, 2012 at 11:30 a.m. PT. 

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com.  A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA; PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU; BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II cl
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin Announces IND for BMN-111 for Achondroplasia is Active
2. BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility
3. Highlights from BioMarins Research & Development Day
4. BioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority
5. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
6. BioMarin Announces FDA Approval of Expanded Biologics Manufacturing Facility
7. BioMarin to Host a Research and Development Day on December 8th
8. BioMarin Announces Third Quarter 2011 Financial Results
9. BioMarin to Present at the UBS Global Life Sciences Conference
10. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
11. BioMarin to Present at the Baird Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015   EVO Aesthetic ... the leading provider for non-invasive aesthetics in ... tattoo removal treatments with the Astanza Duality laser. The ... well being through various medical and laser procedures. Their ... unwanted ink a clear solution to their tattoo regret. ...
(Date:7/2/2015)... July 2, 2015   Decision Resources Group ... specialists identify less frequent dosing as the highest ... to the burden on both patients and providers ... factor (VEGF) injections, which are the current standard ... pegol, which is in development for dosing every ...
(Date:7/2/2015)... 2015  Konica Minolta, Inc. (Konica Minolta) ( ... acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer ... through its Brazilian healthcare sales company, Konica Minolta Healthcare ... Brazil market investment and growth ... 200 million, significant healthcare technical advancements and efficiencies are ...
Breaking Medicine Technology:EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... , MONTREAL, Oct. 14 During tough economic times, ... Global Vision,s automated inspection solutions in an effort to ... products. , First Priority,s previous method of inspection ... secondary packaging. Along with manual inspection came heavy labor ...
... N.J., Oct. 14 Weekly Digest ( http://www.bullmarket.com/digest ... publication of a special report on investment opportunities in ... updated outlooks for Gilead Sciences (Nasdaq: GILD ), ... DVAX ), Hemispherx BioPharma (Amex: HEB ), ...
Cached Medicine Technology:Global Vision Helps First Priority Reduce Costs in Tough Times 2Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak 2
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why ... here to read the complete story , just posted on the Surviving Mesothelioma website. ... and New York University exposed mice with a mutation on the tumor suppressor gene ...
(Date:7/3/2015)... NY (PRWEB) , ... July 03, 2015 , ... ... Learning Lecture took place on June 25, 2015 at 1:00pm. The Association welcomed ... explored issues pertaining to injured bicyclists and practical points of investigating these types ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... Director of its Frisco facility. , “We are pleased to announce that Dr. Manzanares ... Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares received ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently ... similar to those of celebrities will have the opportunity to get 10% discount on ... ensures that people do not have to use coupon codes or remember redemption codes. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on ... American society right now," Becic said. "We must understand the magnitude of this discovery. ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... President Obama signed the Christopher and Dana Reeve Paralysis ... life for people living with paralysis and mobility impairments ... and others. The legislation authorizes Congress to fund $25,000,000 ... Christopher and Dana Reeve Paralysis Act Title XIV of ...
... FRIENDSWOOD, Texas, March 30 TrinityCare Senior Living, ... and owns faith-based senior living facilities, today announced ... to develop and implement a comprehensive investor relations ... is an investment research and financial communications firm ...
... Becoming the first long term care company in ... Healthcare and its affiliates today announced the completion of ... by an Employee Stock Ownership Plan (ESOP) Trust. ... can provide for our devoted employees who, we hope, ...
... Camp Courage in Maple Lake, Minn., is hosting ... campers and the general public interested in learning more ... hand to give tours and answer questions from 2-4 ... Street NW, Maple Lake, Minn. Call the camp office ...
... 30 Hospira, Inc. (NYSE: HSP ), ... today announced that it will host a conference call ... 28, 2009, at 8 a.m. Central time. The ... morning, before the U.S. stock market open and the ...
... 30, 2009 A study published in a special ... emerging practice of drug delivery systems which use the ... , The process uses biocompatible materials that are ... Changes in external or internal body conditions can be ...
Cached Medicine News:Health News:United Spinal Association Praises Historic Signing of the Christopher and Dana Reeve Paralysis Act 2Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 2Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 3Health News:Evergreen Healthcare L.L.C. Announces 100% Employee Ownership 2Health News:Camp Courage Hosts Open House Sunday, April 26 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: